Jacobi Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Jacobi Capital Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$13K	–	1387
2021 Q3	$13K	Hold	200	–	–	﹤0.01%	997
2021 Q2	$13K	Hold	200	–	–	﹤0.01%	966
2021 Q1	$12K	Hold	200	–	–	﹤0.01%	934
2020 Q4	$10K	Hold	200	–	–	﹤0.01%	883
2020 Q3	$10K	Hold	200	–	–	﹤0.01%	812
2020 Q2	$7K	Hold	200	–	–	﹤0.01%	860
2020 Q1	$5K	Hold	200	–	–	﹤0.01%	832
2019 Q4	$6K	Buy	+200	New	+$4.77K	﹤0.01%	834

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Jacobi Capital Management's AXNX Position: Q4 2021 in Review

Jacobi Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2021, closing a stake of 200 shares — an estimated $13K sold.

Jacobi Capital Management first reported a position in AXNX in Q4 2019 and held it in 8 quarters. The position peaked at $13K in Q3 2021. 180 funds tracked by Wall St. Rank hold AXNX as of Q4 2021.

Jacobi Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 200 Axonics, Inc. Common Stock shares in Q4 2021, an estimated $13K.
Jacobi Capital Management first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Jacobi Capital Management's Axonics, Inc. Common Stock position peaked at $13K in Q3 2021.
180 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.